Development of novel therapeutics for all individuals with CF (the future goes on)

Files in this item

Files Size Format View
By request of the author, access to this item is restricted. See below for more details.

This item appears in the following Collection(s)

© 2022, European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. This manuscript version is made available under the CC BY-NC-ND 4.0 license. Except where otherwise noted, this item's license is described as © 2022, European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. This manuscript version is made available under the CC BY-NC-ND 4.0 license.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement